Kefeng Dou
Overview
Explore the profile of Kefeng Dou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
2442
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ma S, Qi R, Han S, Li Z, Zhang X, Wang G, et al.
Chin Med J (Engl)
. 2024 Oct;
PMID: 39420636
Background: The primary limitation to kidney transplantation is organ shortage. Recent progress in gene editing and immunosuppressive regimens has made xenotransplantation with porcine organs a possibility. However, evidence in pig-to-human...
2.
Intensive Surveillance of Porcine-Rhesus Kidney Xenotransplant Using Different Ultrasound Techniques
Qi R, Ma S, Han S, Wang G, Zhang X, Liu K, et al.
Xenotransplantation
. 2024 Jul;
31(4):e12873.
PMID: 38961605
Background: Significant progress has been made in kidney xenotransplantation in the past few years, and this field is accelerating towards clinical translation. Therefore, surveillance of the xenograft with appropriate tools...
3.
Lin Z, Zhang X, Wang J, Liu W, Liu Q, Ye Y, et al.
Cell Death Dis
. 2024 Apr;
15(4):245.
PMID: 38575588
No abstract available.
4.
Lin Z, Yang P, Hu Y, Xu H, Duan J, He F, et al.
Nat Commun
. 2023 Oct;
14(1):6635.
PMID: 37857628
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disorder worldwide. Recent studies show that innate immunity-related signaling pathways fuel NAFLD progression. This study aims to identify potent regulators...
5.
Tian Z, Xu C, He W, Lin Z, Zhang W, Tao K, et al.
Cancer Lett
. 2023 Oct;
577:216439.
PMID: 37832781
Hippo pathway plays a crucial role in the progression of hepatocellular carcinoma (HCC), and yes-associated protein (YAP) is one of the major factors of the Hippo pathway. However, the mechanism...
6.
Yang X, Qu S, Wang L, Zhang H, Yang Z, Wang J, et al.
Oncogene
. 2023 Mar;
42(15):1263.
PMID: 36890279
No abstract available.
7.
Fang Z, Xu H, Duan J, Ruan B, Liu J, Song P, et al.
Signal Transduct Target Ther
. 2023 Mar;
8(1):94.
PMID: 36864030
Nonalcoholic fatty liver disease (NAFLD) which is a leading cause of chronic liver diseases lacks effective treatment. Tamoxifen has been proven to be the first-line chemotherapy for several solid tumors...
8.
Zhang X, Cooper D, Dou K
Sci Bull (Beijing)
. 2022 Dec;
67(18):1827-1829.
PMID: 36546291
No abstract available.
9.
Tian Z, Xu C, Yang P, Lin Z, Wu W, Zhang W, et al.
Front Immunol
. 2022 Oct;
13:984728.
PMID: 36189208
Hepatocellular carcinoma(HCC) is the sixth most common cancer in the world and is usually caused by viral hepatitis (HBV and HCV), alcoholic, and non-alcoholic fatty liver disease(NAFLD). Viral hepatitis accounts...
10.
Wu W, Wang Q, Han D, Li J, Nie Y, Guo D, et al.
Cancer Cell Int
. 2021 Sep;
21(1):500.
PMID: 34535132
Background: The prognosis of hepatocellular carcinoma (HCC) is not optimistic. Our study focused on present inflammatory markers, including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), gamma-glutamyl transpeptidase-to-platelet ratio (GPR), aspartate...